1. Ani C, Ovbiagele B. Elevated red blood cell distribution width predicts mortality in persons with known stroke. J Neurol Sci. 277(1-2):103-8 (2009).

2. Bang OY, Saver JL, Liebeskind DS, Lee PH, Sheen SS, Yoon SR, Yun SW, Kim GM, Chung CS, Lee KH, Ovbiagele B. Age-distinct predictors of symptomatic cervicocephalic atherosclerosis. Cerebrovasc Dis. 27(1):13-21 (2009).

3. Sanossian N, Gatto NM, Ovbiagele B. Patterns of influenza vaccination among stroke survivors. Neuroepidemiology. 32(3):165-70 (2009).

4. Ovbiagele B, McNair N, Pineda S, Liebeskind DS, Ali LK, Saver JL. A care pathway to boost influenza vaccination rates among inpatients with acute ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis. 18(1):38-40 (2009).

5. Bang OY, Saver JL, Alger JR, Shah SH, Buck BH, Starkman S, Ovbiagele B, Liebeskind DS. Patterns and predictors of blood-brain barrier permeability derangements in acute ischemic stroke. Stroke. 40(2):454-61 (2009).

6. Ovbiagele B. Association of ankle-brachial index level with stroke. J Neurol Sci. 276(1-2):14-7 (2009).

7. Ling G, Ovbiagele B. Oral antiplatelet therapy in the secondary prevention of atherothrombotic events. Am J Cardiovasc Drugs. 9(3):197-209 (2009).

8. Bang OY, Ovbiagele B, Liebeskind DS, Restrepo L, Yoon SR, Saver JL. Clinical determinants of infarct pattern subtypes in large vessel atherosclerotic stroke. J Neurol. 256(4):591-9 (2009).

9. Yoon SR, Bang OY, Hong JM, Li WY, Lee PH, Ovbiagele B. Non-conventional risk factors were associated with infarct patterns in ischemic stroke. Clin Neurol Neurosurg. 111(2):134-9 (2009).

10. Bang OY, Saver JL, Liebeskind DS, Pineda S, Yun SW, Ovbiagele B. Impact of metabolic syndrome on distribution of cervicocephalic atherosclerosis: Data from a diverse race-ethnic group. J Neurol Sci. 2009 Apr 25; (2009).

11. Zurru MC, Alonzo C, Brescacin L, Romano M, Camera LA, Waisman G, Cristiano E, Ovbiagele B. Recent respiratory infection predicts atherothrombotic stroke: case-control study in a Buenos Aires healthcare system. Stroke. 40(6):1986-90 (2009).

12. Towfighi A, Ovbiagele B. The impact of body mass index on mortality after stroke. Stroke. 40(8):2704-8 (2009).

13. Ovbiagele B, Buck BH, Liebeskind DS, Starkman S, Bang OY, Ali LK, Villablanca JP, Salamon N, Yun SW, Pineda S, Saver JL. Prior antiplatelet use and infarct volume in ischemic stroke. J Neurol Sci. 264(1-2):140-4 (2008).

14. Ovbiagele B. Antiplatelet Therapy in Management of Transient Ischemic Attack: Overview and Evidence-based Rationale. J Emerg Med. 2008 Jan 17; (2008).

15. Rahiman A, Saver JL, Porter V, Buxton W, McNair N, Razinia T, Ovbiagele B. In-hospital initiation of secondary prevention is associated with improved vascular outcomes at 3 months. J Stroke Cerebrovasc Dis. 17(1):5-8 (2008).

16. Rajajee V, Kidwell C, Starkman S, Ovbiagele B, Alger J, Villablanca P, Saver JL. Diagnosis of lacunar infarcts within 6 hours of onset by clinical and CT criteria versus MRI. J Neuroimaging. 18(1):66-72 (2008).

17. Sanossian N, Ovbiagele B. Drug insight: translating evidence on statin therapy into clinical benefits. Nat Clin Pract Neurol. 4(1):43-9 (2008).

18. Buck BH, Liebeskind DS, Saver JL, Bang OY, Yun SW, Starkman S, Ali LK, Kim D, Villablanca JP, Salamon N, Razinia T, Ovbiagele B. Early neutrophilia is associated with volume of ischemic tissue in acute stroke. Stroke. 39(2):355-60 (2008).

19. Towfighi A, Ovbiagele B. Metabolic syndrome and stroke. Curr Diab Rep. 8(1):37-41 (2008).

20. Ovbiagele B, Drogan O, Koroshetz WJ, Fayad P, Saver JL. Outpatient practice patterns after stroke hospitalization among neurologists. Stroke. 39(6):1850-4 (2008).

21. Pineda S, Bang OY, Saver JL, Starkman S, Yun SW, Liebeskind DS, Kim D, Ali LK, Shah SH, Ovbiagele B. Association of serum bilirubin with ischemic stroke outcomes. J Stroke Cerebrovasc Dis. 17(3):147-52 (2008).

22. Ovbiagele B, Hutchison P, Handschumacher L, Coleman A, Gutierrez M, Yellin-Mednick S, Beanes S, Cooper EM, Pratt FD. Educating and mobilizing youth to detect undiagnosed elevated blood pressure: searching for the silent killer. Ethn Dis. 18(1):84-8 (2008).

23. Bang OY, Saver JL, Alger JR, Shah SH, Buck BH, Starkman S, Ovbiagele B, Liebeskind DS. Patterns and Predictors of Blood-Brain Barrier Permeability Derangements in Acute Ischemic Stroke. Stroke. 2008 Nov 26; (2008).

24. Shah SH, Engelhardt R, Ovbiagele B. Patterns of complementary and alternative medicine use among United States stroke survivors. J Neurol Sci. 271(1-2):180-5 (2008).

25. Ovbiagele B. Microalbuminuria: risk factor and potential therapeutic target for stroke?. J Neurol Sci. 271(1-2):21-8 (2008).

26. Ovbiagele B, Cruz-Flores S, Lynn MJ, Chimowitz MI. Early stroke risk after transient ischemic attack among individuals with symptomatic intracranial artery stenosis. Arch Neurol. 65(6):733-7 (2008).

27. Nazliel B, Starkman S, Liebeskind DS, Ovbiagele B, Kim D, Sanossian N, Ali L, Buck B, Villablanca P, Vinuela F, Duckwiler G, Jahan R, Saver JL. A brief prehospital stroke severity scale identifies ischemic stroke patients harboring persisting large arterial occlusions. Stroke. 39(8):2264-7 (2008).

28. Ovbiagele B, Starkman S, Teal P, Lyden P, Kaste M, Davis SM, Hacke W, Fierus M, Saver JL. Serum calcium as prognosticator in ischemic stroke. Stroke. 39(8):2231-6 (2008).

29. Ovbiagele B. Pessin Award Lecture 2008: Lessons from the Stroke PROTECT program. J Neurol Sci. 275(1-2):1-6 (2008).

30. Ovbiagele B. Association of ankle-brachial index level with stroke. J Neurol Sci. 2008 Sep 17; (2008).

31. Towfighi A, Ovbiagele B. Partial peroxisome proliferator-activated receptor agonist angiotensin receptor blockers. Potential multipronged strategy in stroke prevention. Cerebrovasc Dis. 26(2):106-12 (2008).

32. Sanossian N, Ovbiagele B. The risk of stroke within a week of minor stroke or transient ischemic attack. Expert Opin Pharmacother. 9(12):2069-76 (2008).

33. Ovbiagele B. Potential role of curcumin in stroke prevention. Expert Rev Neurother. 8(8):1175-6 (2008).

34. Ovbiagele B. Antiplatelet therapy in management of transient ischemic attack: overview and evidence-based rationale. J Emerg Med. 34(4):389-96 (2008).

35. Ovbiagele B. Impairment in glomerular filtration rate or glomerular filtration barrier and occurrence of stroke. Arch Neurol. 65(7):934-8 (2008).

36. Towfighi A, Saver JL, Engelhardt R, Ovbiagele B. Factors associated with the steep increase in late-midlife stroke occurrence among US men. J Stroke Cerebrovasc Dis. 17(4):165-8 (2008).

37. Yoon SR, Bang OY, Hong JM, Li WY, Lee PH, Ovbiagele B. Non-conventional risk factors were associated with infarct patterns in ischemic stroke. Clin Neurol Neurosurg. 2008 Nov 1; (2008).

38. Sanossian N, Ovbiagele B. Probing racial and regional disparities in stroke mortality: same problem, different solutions?. Ann Neurol. 64(5):483-4 (2008).

39. Bang OY, Saver JL, Liebeskind DS, Lee PH, Sheen SS, Yoon SR, Yun SW, Kim GM, Chung CS, Lee KH, Ovbiagele B. Age-Distinct Predictors of Symptomatic Cervicocephalic Atherosclerosis. Cerebrovasc Dis. 27(1):13-21 (2008).

40. Bang OY, Liebeskind DS, Buck BH, Yoon SR, Alger JR, Ovbiagele B, Saver JL. Impact of Reperfusion after 3 Hours of Symptom Onset on Tissue Fate in Acute Cerebral Ischemia. J Neuroimaging. 2008 Oct 21; (2008).

41. Ani C, Ovbiagele B. Elevated red blood cell distribution width predicts mortality in persons with known stroke. J Neurol Sci. 2008 Nov 22; (2008).

42. Sanossian N, Gatto NM, Ovbiagele B. Patterns of Influenza Vaccination among Stroke Survivors. Neuroepidemiology. 32(3):165-170 (2008).

43. Ovbiagele B. Pessin award lecture 2008: lessons from the Stroke PROTECT program. J Neurol Sci. 275(1-2):1-6 (2008).

44. Sanossian N, Saver JL, Navab M, Ovbiagele B. High-density lipoprotein cholesterol: an emerging target for stroke treatment. Stroke. 38(3):1104-9 (2007).

45. Buck BH, Liebeskind DS, Saver JL, Bang OY, Starkman S, Ali LK, Kim D, Villablanca JP, Salamon N, Yun SW, Razinia T, Ovbiagele B. Association of higher serum calcium levels with smaller infarct volumes in acute ischemic stroke. Arch Neurol. 64(9):1287-91 (2007).

46. Bang OY, Buck BH, Saver JL, Alger JR, Yoon SR, Starkman S, Ovbiagele B, Kim D, Ali LK, Sanossian N, Jahan R, Duckwiler GR, Vinuela F, Salamon N, Villablanca JP, Liebeskind DS. Prediction of hemorrhagic transformation after recanalization therapy using T2*-permeability magnetic resonance imaging. Ann Neurol. 2007 Aug 7; (2007).

47. Ovbiagele B. Statin therapy after stroke or transient ischemic attack-a new weapon in our secondary stroke prevention arsenal?. Nat Clin Pract Neurol. 2007 Jan 23; (2007).

48. Ovbiagele B, Lynn MJ, Saver JL, Chimowitz MI. Leukocyte count and vascular risk in symptomatic intracranial atherosclerosis. Cerebrovasc Dis. 24(2-3):283-8 (2007).

49. Towfighi A, Saver JL, Engelhardt R, Ovbiagele B. A midlife stroke surge among women in the United States. Neurology. 2007 Jun 20; (2007).

50. Viehman JA, Saver JL, Liebeskind DS, Starkman S, Ali LK, Buck B, Razinia T, Ovbiagele B. Utility of urinalysis in discriminating cardioembolic stroke mechanism. Arch Neurol. 64(5):667-70 (2007).

51. Ovbiagele B. Statin therapy after stroke or transient ischemic attack--a new weapon in our secondary stroke prevention arsenal?. Nat Clin Pract Neurol. 3(3):130-1 (2007).

52. Ovbiagele B, Saver JL. Intensive statin therapy after stroke or transient ischemic attack: a SPARCLing success?. Stroke. 38(3):1110-2 (2007).

53. Razinia T, Saver JL, Liebeskind DS, Ali LK, Buck B, Ovbiagele B. Body mass index and hospital discharge outcomes after ischemic stroke. Arch Neurol. 64(3):388-91 (2007).

54. Ovbiagele B, Sachdeva S. Preventing another event: role of the hospitalist in discharge stroke prevention. J Hosp Med. 2(1):31-8 (2007).

55. Ovbiagele B, Saver JL. Intensive statin therapy after stroke or transient ischemic attack: a sparcling success?. Stroke. 38(3):1110-2 (2007).

56. Ovbiagele B, Buck BH, Liebeskind DS, Starkman S, Bang OY, Ali LK, Villablanca JP, Salamon N, Yun SW, Pineda S, Saver JL. Prior antiplatelet use and infarct volume in ischemic stroke. J Neurol Sci. 2007 Sep 11; (2007).

57. Bang OY, Saver JL, Buck BH, Alger JR, Starkman S, Ovbiagele B, Kim D, Jahan R, Duckwiler GR, Yoon SR, Vinuela F, Liebeskind DS. Impact of collateral flow on tissue fate in acute ischemic stroke. J Neurol Neurosurg Psychiatry. 2007 Dec 20; (2007).

58. Buck BH, Liebeskind DS, Saver JL, Bang OY, Yun SW, Starkman S, Ali LK, Kim D, Villablanca JP, Salamon N, Razinia T, Ovbiagele B. Early Neutrophilia Is Associated With Volume of Ischemic Tissue in Acute Stroke. Stroke. 2007 Dec 27; (2007).

59. Ovbiagele B. The emergency department: first line of defense in preventing secondary stroke. Acad Emerg Med. 13(2):215-22 (2006).

60. Ovbiagele B, Weir CJ, Saver JL, Muir KW, Lees KR. Effect of Smoking Status on Outcome after Acute Ischemic Stroke. Cerebrovasc Dis. 21(4):260-265 (2006).

61. Ovbiagele B. The Emergency Department: First Line of Defense in Preventing Secondary Stroke. Acad Emerg Med. 2006 Jan 25; (2006).

62. Ovbiagele B, Saver JL. Ensuring management of vascular risk factors after stroke. Rev Neurol Dis. 3(3):93-100 (2006).

63. Ovbiagele B, Levine SR. Addressing racial and ethnic disparities in stroke: the time is now. Neurology. 67(8):1328-9 (2006).

64. Sanossian N, Saver JL, Ovbiagele B. Aspirin and stroke severity. Stroke. 37(11):2660; author reply (2006).

65. Sanossian N, Ohanian AG, Saver JL, Kim LI, Ovbiagele B. Frequency and determinants of nonpublication of research in the stroke literature. Stroke. 37(10):2588-92 (2006).

66. Sanossian N, Saver JL, Ovbiagele B. Aspirin and Stroke Severity. Stroke. 2006 Sep 14; (2006).

67. Sanossian N, Ohanian AG, Saver JL, Kim LI, Ovbiagele B. Frequency and Determinants of Nonpublication of Research in the Stroke Literature. Stroke. 2006 Aug 24; (2006).

68. Sanossian N, Saver JL, Liebeskind DS, Kim D, Razinia T, Ovbiagele B. Achieving target cholesterol goals after stroke: is in-hospital statin initiation the key?. Arch Neurol. 63(8):1081-3 (2006).

69. Cardenas D, Ovbiagele B. Arterial dissection and cerebral venous thrombosis in sickle cell trait. Br J Hosp Med (Lond). 67(7):380-1 (2006).

70. Ovbiagele B, Saver JL, Sanossian N, Salamon N, Villablanca P, Alger JR, Razinia T, Kim D, Liebeskind DS. Predictors of Cerebral Microbleeds in Acute Ischemic Stroke and TIA Patients. Cerebrovasc Dis. 22(5-6):378-383 (2006).

71. Ovbiagele B, Saver JL. Cerebral white matter hyperintensities on MRI: Current concepts and therapeutic implications. Cerebrovasc Dis. 22(2-3):83-90 (2006).

72. Ovbiagele B. Cholesterol and risk of stroke: study lumps apples and oranges. BMJ. 333(7559):148 (2006).

73. Marder VJ, Chute DJ, Starkman S, Abolian AM, Kidwell C, Liebeskind D, Ovbiagele B, Vinuela F, Duckwiler G, Jahan R, Vespa PM, Selco S, Rajajee V, Kim D, Sanossian N, Saver JL. Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke. 37(8):2086-93 (2006).

74. Sanossian N, Ovbiagele B. Multimodality stroke prevention. Neurologist. 12(1):14-31 (2006).

75. Ovbiagele B, Saver JL, Lynn MJ, Chimowitz M. Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis. Neurology. 66(9):1344-9 (2006).

76. Ovbiagele B, Saver JL. Cerebral White Matter Hyperintensities on MRI: Current Concepts and Therapeutic Implications. Cerebrovasc Dis. 22(2-3):83-90 (2006).

77. Marder VJ, Chute DJ, Starkman S, Abolian AM, Kidwell C, Liebeskind D, Ovbiagele B, Vinuela F, Duckwiler G, Jahan R, Vespa PM, Selco S, Rajajee V, Kim D, Sanossian N, Saver JL. Analysis of Thrombi Retrieved From Cerebral Arteries of Patients With Acute Ischemic Stroke. Stroke. 2006 Jun 22; (2006).

78. Ovbiagele B. Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology. 66(3):459; author reply 4 (2006).

79. Ovbiagele B, Hills NK, Saver JL, Johnston SC. Secondary-prevention drug prescription in the very elderly after ischemic stroke or TIA. Neurology. 66(3):313-8 (2006).

80. Ovbiagele B, Weir CJ, Saver JL, Muir KW, Lees KR. Effect of smoking status on outcome after acute ischemic stroke. Cerebrovasc Dis. 21(4):260-5 (2006).

81. Saver JL, Kidwell C, Eckstein M, Ovbiagele B, Starkman S. Physician-investigator phone elicitation of consent in the field: a novel method to obtain explicit informed consent for prehospital clinical research. Prehosp Emerg Care. 10(2):182-5 (2006).

82. Ovbiagele B, Hills NK, Saver JL, Johnston SC. Lipid assessment and treatment patterns in hospitalized TIA and ischemic stroke patients. J Hosp Med. 1(4):214-20 (2006).

83. Fogel B, Cardenas D, Ovbiagele B. Magnetic resonance imaging abnormalities in the corpus callosum of a patient with neuropsychiatric lupus. Neurologist. 12(5):271-3 (2006).

84. Ovbiagele B, Saver JL, Sanossian N, Salamon N, Villablanca P, Alger JR, Razinia T, Kim D, Liebeskind DS. Predictors of cerebral microbleeds in acute ischemic stroke and TIA patients. Cerebrovasc Dis. 22(5-6):378-83 (2006).

85. Sanossian N, Saver JL, Kim D, Razinia T, Ovbiagele B. Do high-density lipoprotein cholesterol levels influence stroke severity?. J Stroke Cerebrovasc Dis. 15(5):187-9 (2006).

86. Ovbiagele B, Hills NK, Saver JL, Johnston SC. Frequency and determinants of pneumonia and urinary tract infection during stroke hospitalization. J Stroke Cerebrovasc Dis. 15(5):209-13 (2006).

87. Ovbiagele B, Hills NK, Saver JL, Johnston SC. Are racial differences in antihypertensive responsiveness reflected in usage after stroke?. J Stroke Cerebrovasc Dis. 15(6):260-5 (2006).

88. Ovbiagele B. High-dose statins in acute coronary syndromes. JAMA. 293(1):36-7; author reply (2005).

89. Ovbiagele B, Kidwell CS, Saver JL. Expanding indications for statins in cerebral ischemia: a quantitative study. Arch Neurol. 62(1):67-72 (2005).

90. Ovbiagele B, Saver JL. Comments on 'when to measure lipid profile after stroke'. Cerebrovasc Dis. 20(3):211 (2005).

91. Ovbiagele B, Kidwell CS, Selco S, Razinia T, Saver JL. Treatment adherence rates one year after initiation of a systematic hospital-based stroke prevention program. Cerebrovasc Dis. 20(4):280-2 (2005).

92. Ovbiagele B. HMG-CoA reductase inhibitors improve acute ischemic stroke outcome. Stroke. 36(11):2344; author reply (2005).

93. Kremen SA, Wu MN, Ovbiagele B. Hemopericardium following intravenous thrombolysis for acute ischemic stroke. Cerebrovasc Dis. 20(6):478-9 (2005).

94. Ovbiagele B, Saver JL. The smoking-thrombolysis paradox and acute ischemic stroke. Neurology. 65(2):293-5 (2005).

95. Ovbiagele B, Hills NK, Saver JL, Johnston SC. Antihypertensive medications prescribed at discharge after an acute ischemic cerebrovascular event. Stroke. 36(9):1944-7 (2005).

96. Suzuki S, Kidwell CS, Starkman S, Saver JL, Duckwiler G, Vinuela F, Ovbiagele B. Use of multimodal MRI and novel endovascular therapies in a patient ineligible for intravenous tissue plasminogen activator. Stroke. 36(9):e77-9 (2005).

97. Bower CM, Morgan L, Ovbiagele B. A patient with left ventricular thrombus and recurrent stereotypic TIAs. Neurology. 65(3):492-3 (2005).

98. Cardenas D, Mishra SK, Ohanian AG, Ovbiagele B. Successive yet distinct episodes of isolated ophthalmoplegia associated with anti-GQ1b antibody. Neurology. 65(1):163 (2005).

99. Bhidayasiri R, Hathout GM, Heyming TW, Ovbiagele B. Cerebellar arteriovenous malformation presenting with bilateral proptosis mimicking caroticocavernous fistula. Hosp Med. 65(11):690-1 (2004).

100. Kidwell CS, Chalela JA, Saver JL, Starkman S, Hill MD, Demchuk AM, Butman JA, Patronas N, Alger JR, Latour LL, Luby ML, Baird AE, Leary MC, Tremwel M, Ovbiagele B, Fredieu A, Suzuki S, Villablanca JP, Davis S, Dunn B, Todd JW, Ezzeddi. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA. 292(15):1823-30 (2004).

101. Ovbiagele B, Saver JL, Fredieu A, Suzuki S, Selco S, Rajajee V, McNair N, Razinia T, Kidwell CS. In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke. 35(12):2879-83 (2004).

102. Leary MC, Kidwell CS, Villablanca JP, Starkman S, Jahan R, Duckwiler GR, Gobin YP, Sykes S, Gough KJ, Ferguson K, Llanes JN, Masamed R, Tremwel M, Ovbiagele B, Vespa PM, Vinuela F, Saver JL. Validation of computed tomographic middle cerebral artery "dot"sign: an angiographic correlation study. Stroke. 34(11):2636-40 (2003).

103. Ovbiagele B, Kidwell CS, Starkman S, Saver JL. Potential Role of Neuroprotective Agents in the Treatment of Patients with Acute Ischemic Stroke. Curr Treat Options Cardiovasc Med. 5(6):441-449 (2003).

104. Ovbiagele B, Kidwell CS, Saver JL. Epidemiological impact in the United States of a tissue-based definition of transient ischemic attack. Stroke. 34(4):919-24 (2003).

105. Ovbiagele B, Kidwell CS, Starkman S, Saver JL. Neuroprotective agents for the treatment of acute ischemic stroke. Curr Neurol Neurosci Rep. 3(1):9-20 (2003).